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Abstract  
Background Patients with musculoskeletal diseases can potentially be assessed by an extended 
scope physiotherapist (ESP) instead of by an orthopaedic surgeon (OS).  
Objectives To evaluate the effectiveness of the diagnostic musculoskeletal assessment performed 
by ESP compared to OS.  
Data sources MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, CINAHL, 
PEDro and reference lists of included studies and previous reviews were searched in November 
2015.  
Eligibility criteria Studies were included if they evaluated adults with a musculoskeletal disease 
referred to an outpatient orthopaedic clinic where a diagnostic assessment had been conducted by an 
ESP. 
Data extraction Data were extracted using a customised data extraction sheet. Two reviewers using 
checklists evaluated methodological independently.  
Results We included one randomised controlled trial and 31 observational studies. Diagnostic 
agreement between ESPs and OSs was 65–100% across studies. Health care cost savings for 
diagnostic assessments performed by ESPs were 27–49% compared to OSs. Overall, 77–100% of 
the patients were satisfied with the ESP assessment.  Results were comparable on diagnostic 
agreement, cost and satisfaction in studies with high, moderate and low risk of bias. 
Limitations Risk of bias in the included studies.  
Conclusion and implication of key findings Diagnostic assessments performed by ESP may be as 
beneficial as or even better than assessment performed by OSs in terms diagnostic agreement, costs 
and satisfaction. However, the methodological quality was generally too low to determine the clear 
effectiveness of ESP assessment, and more high quality studies are needed.  
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Systematic review registration number: PROSPERO CRD42014014229  
 
Contribution of the Paper 
- Diagnostic assessments seem to be effectively performed by ESPs with regard to diagnostic 
accuracy, satisfaction and health care costs. 
- The methodological quality of studies evaluating the effectiveness of diagnostic assessments 
performed by ESPs is low, and evidence to determine the true effectiveness of ESP 
assessment is therefore lacking.  
- At present, this systematic review is the largest on this topic. 
 
Keywords:  
1. Physical Therapists  
2. Orthopaedics  
3. Musculoskeletal Diseases  
4. Systematic Review 
5. Clinical Decision-Making 
6. Patient Satisfaction  
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Introduction 
Musculoskeletal disease is the second largest global cause of disease [1] and yearly musculoskeletal 
pain is reported by 45% - 74% of the population. [2] Orthopaedic surgeons (OS) are the most 
common consulted specialists for this disease [2,3]. However, many referrals do not meet the 
indications for orthopaedic surgery [2-7] and could potentially be managed by a physiotherapist 
with special training.  
 
In light of this, increasing reports, particular from the United Kingdom (UK) and Australia, use 
specially trained physiotherapists to perform musculoskeletal assessment of patients referred to an 
orthopaedic clinic [8]. The rationale for using physiotherapists instead of OSs to perform 
assessments is to reduce the load on OSs [2], reduce health care costs [9], and to shorten the 
orthopaedic wait time [9,10]. However, it is crucial that assessment quality is ensured, and if this 
procedure is going to be implemented worldwide, that patients and general practitioners (GP) are 
satisfied with the physiotherapists' assessments. 
 
A consistent term for these specially trained physiotherapists is lacking why extended scope 
physiotherapists (ESP) [8,11], clinical specialist physiotherapist (CSP) [4,12], advanced practice 
physiotherapists (APP) [13] and simply physiotherapists [6,10] are used synonymously. In this 
review we use the term ESP. A clear definition of ESPs roles is also lacking [8] and tasks vary 
depending on requirements and legislation [8] - for instance some ESPs do injections, compile 
surgery lists and/or request imaging [2,7]. However, some agreement exists: ESPs are clinical 
specialists working in expanded roles and often with wide experience as practitioners and additional 
training in musculoskeletal physiotherapy [5,9,10,14].  
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Previous systematic reviews evaluating ESPs effectiveness in handling patients with 
musculoskeletal diseases indicate that ESPs have the ability to diagnose musculoskeletal conditions, 
identify patients who need surgery, and that patients are satisfied with ESPs treatment [8,11,13,15]. 
However, these reviews conclude that the evidence is scarce and that high quality research is 
needed [8,11,13]. Since the publication of previous reviews six new studies have been published 
[3,4,5,10,12,14]. Based on this, we decided to perform a comprehensive systematic review with the 
aim to evaluate the effect of using ESPs to make diagnostic assessments. 
 
Objectives 
Main outcomes are  
I) Diagnostic agreement of assessments performed by ESPs and OSs, and diagnostic 
agreement of assessments performed by ESPs and OSs compared to arthroscopy, medical 
imaging or surgical findings 
II) Costs of diagnostic assessments performed by ESPs as compared to assessments performed 
by OSs  
III) Patient and GP satisfaction with diagnostic assessments performed by ESPs 
Additional outcomes are  
IV) Wait time for initial orthopaedic (ESP or OS) assessment  
V) Relevant referrals by evaluating  
o Number of patients managed solely by ESPs  
o Surgical conversion rate of patients referred from ESPs to OSs and later operated on 
 
Methods 
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The study was pre-registered in the PROSPERO database (registration number CRD42014014229). 
The PRISMA guidelines were used for reporting [16]. 
 
Eligibility criteria  
Studies were included if they met the following criteria: (i) adult participants (18+) with a 
musculoskeletal disease referred to an orthopaedic outpatient clinic, (ii) diagnostic assessments 
performed by ESP, (iii) evaluated at least one of these outcomes: diagnostic agreement, costs, 
patient or GP satisfaction, wait time and/or relevant referrals, (iv) original studies published in peer-
reviewed scientific journals, in English, Danish, Norwegian or Swedish. Exclusion criteria were: 
non-orthopaedic, primary care or emergency settings, no separate results for ESPs or the following 
study types: reviews, case series, case reports, opinion-articles, commentaries and conference 
abstracts.  
 
Information sources and search  
Literature was searched until November 2015 conducted by one author (JT) and a research librarian 
until. Studies were identified by searching five databases (MEDLINE, Cochrane Central Register of 
Controlled Trials (CENTRAL), EMBASE, CINAHL and PEDro) (Table S1) and by searching the 
reference lists of identified studies and reviews.  
 
Study selection 
Identified studies were downloaded into Endnote (Endnote basic) and duplicates were manually 
removed. Two authors (JT and LRM) independently screened all titles and abstracts for eligibility. 
Full-text studies were obtained if one of the authors found it relevant according to the inclusion 
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criteria. The same two authors independently reviewed full-text studies, and consensus on inclusion 
was reached by discussion.  
 
Data collection and extraction  
The following data was extracted from the included articles by the main author (JT): (i) author, year 
and country of origin, (ii) study design, (iii) number of participants, (iv) affected body part, (v) 
reported study outcomes, (vi) main results according to reported study outcome and (vii) ESP 
experience and training. A second author (LRM) validated the extracted data. Disagreements were 
resolved by consensus.  
 
Methodological quality assessment 
Two authors (JT and LRM) independently appraised risk of bias with SIGN 50 checklists [17]. 
Studies reporting on one of the main outcomes were assessed with methodological checklists 
according to study outcome: studies evaluating diagnostic accuracy were assessed with the checklist 
for diagnostic accuracy, studies evaluating costs were assessed with the checklist for economic 
evaluations, and studies evaluating satisfaction were assessed with the checklist for cohort studies. 
Studies evaluating more than one of the main outcomes were assessed with methodology checklists 
according to each outcome. Studies reporting only on the additional outcomes (wait time and 
relevant referrals) were not assessed with methodology checklists as no appropriate checklists have 
been developed for these outcomes. Each methodological quality item and the overall quality were 
reported for each study. Disagreements were noted and resolved by consensus with a third author 
(CJ). Overall study quality was rated as “High” when the majority of criteria were met and the study 
had little or no risk bias, as “Acceptable” when most criteria were met but some flaws in the study 
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were associated with risk of bias, and as “Low” when either most criteria were not met or 
significant flaws were related to key aspects [17].  
  
Summary measure and planned methods of analysis  
Meta-analyses were planned evaluating the main outcomes. Diagnostic agreement was evaluated by 
assessing percentage inter-rater agreement (median value, interquartile range (IQR)) and with kappa 
statistics. Cost was evaluated as incremental cost-effectiveness ratio (ICER) or as percentage 
(median, IQR) of cost savings. The primary perspective of the cost evaluation was a health care 
perspective, but patient and primary care perspective were evaluated when reported in included 
studies. Satisfaction, relevant referrals and wait time were all evaluated as percentages (median, 
IQR).  
 
Results 
Study selection 
A total of 3536 studies were identified. After duplicate removal 3104 references remained, of which 
74 studies were assessed in full text. Thirty-two studies were included (Figure S2) of which 23 
(Table 1) evaluated at least one main outcome. 
 
Study characteristics  
Included studies consisted of one randomised controlled trial and 31 observational studies (14 
prospective and 17 retrospective). These studies were conducted in UK (n = 16), Canada (n = 8), 
Australia (n = 4) and Ireland (n = 4). The musculoskeletal diseases encompassed knee (n = 13), 
spine (n = 10), shoulder (n = 7), hip (n = 4) or diverse musculoskeletal parts (n = 9). Number of 
participants varied from 25 [18] to 2146 [19]. ESP experience with specialist musculoskeletal 
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physiotherapy varied from months [20] up to 30 years [3,6], and education in addition to 
physiotherapy training varied with: master’s degree, advanced training in e.g. low back pain, knee 
or arthritis and injection therapy (Table 1 and S3). 
Due to large variation in reported outcome measures only data from a small subgroup of studies 
within a specific outcome could have been pooled in meta-analyses. To avoid misleading outcomes 
we therefore did not perform any meta-analyses. 
 
Diagnostic agreement 
Twelve studies evaluated diagnostic agreement including 650 patients (Table 1). Diagnostic 
agreement for assessments performed by ESP compared to assessments performed by OS ranged 
from 65 to 100% (84%, 74% - 90%) (n = 9) [3,7,10,18,21-25]. When ESP and OS assessments were 
compared to arthroscopy, medical imaging or surgical findings (n = 5) [9,18,21,26,27], the 
diagnostic agreement was comparable for the clinicians since agreements ranged from 52 to 88% 
(78%, 68% - 83%) for ESP assessments and 37 to 92% (79%, 66% - 85%) for OS assessments.  
The overall percentage of diagnostic agreement between ESP and OS assessments was comparable 
for studies with high (n = 4) and acceptable (n = 4) methodological quality, ranging from 76 to 93% 
(86%, 82% - 89%) and from 65 to 90% (72%, 68% - 78%), respectively. The highest diagnostic 
agreement was however found in a study with low methodological quality (100% agreement). 
Kappa values ranged from 0.38 to 0.86 (n = 4), with the highest kappa values in the studies with 
high methodological quality. Diagnostic agreement when ESP and OS diagnosis was compared to 
arthroscopy, medical imaging or surgical findings was highest in the study with high 
methodological quality (84%, 82% - 88%) compared to studies with acceptable (79%, 75% - 82%) 
(n = 3) or low (45%, 41% - 48%) (n = 1) quality (Table S4). According to body part diagnostic 
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agreement was comparable; as for knee, hip and shoulder it was 76–89% (88%, 82% - 89%), 82% 
and 65–100% (83%, 74% - 91%), respectively. 
 
Costs  
Three studies performed a cost evaluation including 1634 patients. In addition, one study presented 
costs in their discussion section (Table 1). The ICER (n = 1) (5) of health care cost for ESP 
compared to OS assessments was Au$ 495 per quality-adjusted life year (QUALY), and the cost 
savings in percentage were 27–49% (31%, 29% - 40%) (n = 3) [14,28,29].  
One study with high methodological quality found that diagnostic assessments performed in a ESP-
led clinic were more expensive but also more beneficial leading to cost-effectiveness compared to 
assessments performed in an OS-led clinic. This conclusion was based on the assumption that 
health care payers will pay a threshold of Au$50 000 per QALYS. In studies where health care cost 
were evaluated in percentage, the cost savings were highest in the study with high methodological 
quality (49 % cost savings), compared to studies with acceptable or low methodological quality 
(27% and 31% cost savings) (Table S5). Variables as salary of specialists (ESP/OS), assessment 
time used, investigations ordered etc. were not consistently included in the analyses. Costs from the 
patient and primary care perspectives were evaluated in one study with high methodological quality, 
which did not find any significant cost difference between assessment performed by ESP or OS.  
 
Satisfaction 
A total of 13 studies evaluated satisfaction with ESP assessment including 1509 patients (plus 
participants from one study with no report of participant number) (Table 1). Proportion of patients 
and GPs being satisfied with ESP assessments ranged from 77 to 100% (89%, 86% - 91%) (n = 8) 
[3,6,10,23,30-33] and from 80 to 96% (95%, 87% - 95%) (n = 5) [6,30,31,33,34], respectively. 
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Three studies compared patient satisfaction between assessments performed by ESP and OS; two 
found satisfaction in favour of ESP (3,7) and one found no difference (28) (Table 1).  
Patient satisfaction with ESP assessment was comparable in studies of high, acceptable and low 
methodological quality but GP satisfaction with ESP assessment was only presented as percentage 
in studies with low methodological quality (Table S6). The “modified VSQ-9 item scale”, a 
standardised tool for measuring satisfaction, was used in two studies [3,7]. Another three studies 
used self-developed instruments [6,28,34], and the remaining eight studies did not describe which 
tool they had used to measure satisfaction.  
 
Wait time and relevant referrals 
Wait time for initial orthopaedic (ESP or OS) assessment (Table S7) was reduced by 26–87% (56%, 
33% - 79%) (n = 5) [7,29,34-36] with ESP assessments, ESP-led clinics or similar solutions.  
Patients assessed by ESP could be managed entirely by the ESP and did not need to see an OS in 
34–99% (71%, 46% - 83%) of cases (n = 14) [4,9,12,14,19,20,29,31-33,35,37-40] and the surgical 
conversion rate of patients referred by an ESP to an OS was 25–91% (69%, 60% - 75%) (n = 10) 
[4,9-12,14,20,32,38,39] (Table S7). 
 
Risk of bias across studies 
All, except one, of the included studies were observational studies, and the methodological quality 
varied greatly, inducing risk of bias [17] (Table S4, S5, S6). The risk of bias concerning diagnostic 
agreement was frequently related to the index test or study flow and timing domains in the included 
studies (Table S4). The risk of bias concerning cost was frequently comprised of lack of sensitivity 
analyses and cost comparisons that were not made on the basis of outcomes in the included studies 
(Table S5). The risk of bias concerning satisfaction was related to retrospective and single group 
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studies, inadequately defined or discussed outcome measures, and to the lack of any mention of 
confounding or confidence intervals (Table S6). 
 
Discussion 
Main findings 
We found 65–100% diagnostic agreement between ESP and OS assessments. When compared to 
medical imaging or surgical findings, the diagnostic agreement for ESP was 52 to 88% and for OS 
37 to 92%. Diagnostic agreement between ESP and OS was highest in a study of low 
methodological quality, but when compared to medical imaging or surgery findings it was highest 
in a study with high methodological quality. Health care costs were reduced by 27–49%, and the 
ICER was AU$ 495 per QUALY was achieved based on studies of mixed methodological quality. 
Furthermore, 77–100% patient and 80–96% of GPs expressed satisfaction when assessments were 
performed by ESP; similar levels of satisfaction were found in studies of mixed methodological 
quality. In addition, assessments performed by ESP reduced wait time by 26-87%, 34–99% of the 
patients did not need to see an OS, and the surgical conversion rate of patients referred by ESP was 
25-91%. The estimates from included studies had wide intervals, and the methodological quality 
varied greatly, but the findings across studies were comparable which suggests that ESP may be 
useful for making musculoskeletal diagnostic assessments.  
 
Comparison with previous reviews 
Our results are in line with previous systematic reviews, which conclude that ESP assessments are 
beneficial in terms of diagnostic accuracy [8,11,13], health care costs [8,13] and patient satisfaction 
[11,13,15]. Previous reviews had included studies with an emergency department [13] or primary 
care [8,11,15] setting, whereas we to increase the internal validity exclusively included studies from 
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orthopaedic outpatient settings.  We planned to be the first to perform meta-analyses on main 
outcomes, but even with inclusion of six newly published studies only data from a small subgroup 
of these studies could have been pooled. Instead we synthesised the results individually for each 
main outcome, which no previoius reviews had done consistently.  
 
Strengths and limitations of the present review  
The main strength of the present review is the comprehensive literature search performed, which 
returned a large number of new studies, making this review the largest on this topic to date. Another 
strength is that our study selection and methodological quality assessment was performed 
independently by two authors who reported individually on quality item for each study. 
Methodological quality was assessed using SIGN 50-checklists with individual items for various 
outcomes. This is relevant because individual items affect dimentions like diagnostic agreement, 
cost and satisfaction differently. SIGN 50 checklists were therefore considered superior to e.g., 
QUEDAS-2 checklists. Furthermore, we minimised the risk of selection bias by including all 
studies regardless of their methodological quality as recommended by the Cochrane Handbook. 
Nevertheless, bias might account for some of the observed effect. More than half of the included 
studies used retrospective data and had only low or acceptable methodological quality, making our 
results susceptible to risk of bias. Eight study outcomes had a "high" methodological quality. 
However, these studies evaluated different outcomes, why we generally consider the 
methodological quality to be low for each outcome. We did not test for publication bias. Still, as the 
results of the included studies are quite consistent, we consider the influence of publication bias to 
be non-critical. We did not search for unpublished studies and did not contact any experts in this 
field, which could induce reporting bias. Three studies [24-26] on diagnostic agreement did not 
provide information regarding ESPs experience and training; and often it was not described whether 
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pre-specified diagnostic categories were used. Only one [5] study on cost performed a sensitivity 
analysis, even if this generally considered necessary to investigate uncertainty of parameters and to 
increase the analysis robustness. Furthermore, only two [3,7] studies used a standardised tool to 
measure satisfaction although this would increase reliability and validity. With the different tools 
used in the remaining 11 studies, it was not clear if they evaluated satisfaction with ESP, with the 
outcome, or with other aspects. ESP and OS assessment time was often not described in the 
included studies. This may have an impact on all the evaluated outcomes. 
The generalisability of the result to other countries than the UK, Australia, Canada and Ireland can 
be questioned as all included studies were conducted in these countries and as assessments were 
performed by a single ESP and/or a single OS in the majority of the studies. We could have 
included studies with a primary care setting and thereby have included more studies as well as a 
Scandinavian study [2]. However, we abstained from this as the scope of this review was an 
orthopaedic outpatient setting, and as study results performed in different settings might show 
contradictory results. 
We recommend conducting new studies in other countries, which should aim for high 
methodological quality, including comprehensive intervention description and using reliable and 
validated tools to evaluate satisfaction. However, justification for ESPs is highly important as 
reducing health care costs and releasing OS time are requested, and as diagnostic assessments 
performed by ESPs may be an effective way to achieve these goals.  
 
Conclusion  
This systematic review indicates that orthopaedic diagnostic assessments performed by ESPs may 
be as beneficial as or even better than assessment performed by OSs in terms of diagnostic 
accuracy, cost and satisfaction. Furthermore, that initial assessments by ESPs may lead to reduced 
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wait time and a large proportion of patients not needing to see an OS. However, the methodological 
quality of the included studies was generally too low to determine a clear effectiveness of ESPs 
role. We therefore encourage more high quality studies on this topic. 
 
Ethical Approval: Ethical approval was not required for this systematic review as it is based on 
published data only. 
Conflict of Interest: There are no conflicts of interest. 
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Table 1 
Main outcome results (n = 23):  Diagnostic agreement (n = 12), costs (n = 4) and satisfaction (n = 13). 
Author, 
Year, 
Country 
Study design, 
Body part 
 
Diagnostic agreement Cost Satisfaction Methodological quality 
ESP and OS  
% (n) 
ESP and OS vs 
imaging, surgical 
findings and 
arthroscopy % (n) 
ESP vs OS (n) 
 
 
 
Pt. % (n)  GP % (n)  
 
 
 
 
Aiken et al.,  
  2008, Canada [25] 
Prospective,  
Knee and hip 
Overall:  
100% (38) 
  ESP: All subjects 
were satisfied (38)  
 Low (D) 
Low (S) 
Aiken et al.,  
  2009, Canada [35] 
Prospective, 
Knee and hip 
   ESP: Satisfaction was 
high or very high with 
all measures (86) 
 Low (S) 
Aiken and McColl,    
  2008, Canada [18] 
Prospective,  
Knee and 
shoulder 
Overall: 90% 
- Knee: 88% (24) 
- Shoulder: 100% 
(6)  
ESP: 75% (8) vs 
MRI or surgical 
findings 
OS: 75% (8) vs MRI 
or surgical findings 
   Acceptable 
(D) 
Ashmore et al.,  
  2014, Ireland [9] 
Retrospective,  
Knee 
 ESP: 88% (25),  
k = 0.80 [CI: 0.58- 
1.00] vs medical 
imaging and/or 
surgical findings 
   Acceptable 
(D) 
Bath and Janzen,   
  2012, Canada [6] 
Prospective,  
Spine 
   ESP: 90% (108);  
66% very and 24% 
somewhat satisfied 
Referring 
health care: 
96%; 91% 
very and 5% 
somewhat 
satisfied 
Acceptable 
(S) 
Blackburn et al.,  
  2009, Australia 
[34] 
Retrospective, 
Spine 
    87%  (12)  Low (S) 
Burn and Beeson,   
  2014, UK [14] 
Prospective,  
Diverse areas 
  Health care perspective: Cost 
savings from triage: £ 28 377 vs 
additional cost from triage: £ 20 
607 = 27% (£ 7770) cost savings 
per year (273) 
  Acceptable 
(C) 
Byles and Ling,  
  1989, UK [33] 
Prospective, 
Diverse areas 
   ESP: 88% satisfied 
(163)  
80% (100)  
 
Low (S) 
Comans  et al., 
  2014, Australia [5] 
 
Retrospective, 
Spine, knee and 
shoulder 
  Health care perspective: Au$ 112 
incremental costs and 0.23 QALYs for 
pts seen by ESP = ICER of Au$ 495 
QUALYs (980) → ESP-led clinics are 
cost-effective compared to OS-led 
clinics if health care payer will pay 
threshold of Au$50 000 per QALYs 
  High (C) 
Daker-White et al.,   
  1999, UK [28] 
 
RCT,  
Diverse areas 
  Health care perspective: £ 256 for ESP 
vs £ 498 for OS per pt. = 49% (£ 242) 
cost savings per year with ESP 
assessments (p<000001) (470) 
ESP vs OS: No 
difference in 
dissatisfaction (p = 
0.2) (n = 398) 
 
 High (C) 
High (S) 
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Patient perspective: £ 89 for ESP vs £ 
50 for OS assessment per pt. (p = 0.8) 
(402). 
Primary care perspective: £ 42 for ESP 
vs £ 36 for OS assessment per pt. (p = 
0.17) (394) 
 
 
Desmeules et al.,   
  2013, Canada [3] 
 
 
Prospective,  
Knee and hip 
 
 
Overall: 88% (120);  
k: 0.86 [CI: 
0.80;0.93] 
- Knee: 89% (109);  
k: 0.87 
[CI:0.79;0.94] 
- Hip: 82% (11) 
   
 
ESP: 93% satisfied 
(112) 
OS: 86% satisfied 
(112) 
ESP vs OS: Favour 
ESP  
(p < 0.0001) 
  
 
High (D) 
High (S) 
Dickens et al., 
  2003, UK [21] 
 
Prospective,  
Knee 
Overall: 76% (17) 
 
 
ESP 1: 84% (33) vs 
arthroscopy 
ESP 2: 80% (33) vs 
arthroscopy 
OS: 92% (33) vs 
arthroscopy 
   High (D) 
Gardiner and 
Turner,   
  2002, UK [26] 
 
Retrospective,  
Knee 
 ESP: 52% (12) vs 
arthroscopy 
OS: 37%  (39) vs 
arthroscopy 
   Low (D) 
Harrison et al., 
  2001, UK [29] 
Retrospective, 
Shoulder 
  £ 11 for ESP vs £ 16 for OS = 31% (£ 
5) cost savings per year (perspective 
and n NR) 
  Low (C) 
Hockin and 
Bannister,  
  1994, UK [31] 
Retrospective, 
Diverse areas 
   ESP: 89% satisfied 
(189)  
 
95% (n NR)  Low (S) 
MacKay et al.,  
  2009, Canada [22] 
Prospective,  
Knee and hip 
Overall: 69% (60)      Acceptable 
(D) 
Napier et al.,  
  2013, Canada [10] 
Prospective,  
Knee and 
shoulder 
Overall: 84% (45);  
k: 0.77 [CI: 
0.60;0.94]  
- Shoulder:  
k: 0.73 [CI: 0.57-
1.00] 
- Knee:  
k: 0.85 [CI: 0.52-
0.94]  
  ESP: 100% (45) 
satisfied or very 
satisfied  
 
 
 High (D) 
Acceptable 
(S) 
Oakes,  
  2009, UK [24] 
Retrospective, 
Shoulder 
Overall: 65% (26)     Acceptable 
(D) 
Oldmeadow et al.,   
  2007, Australia 
[23] 
Prospective, 
Knee, shoulder 
and spine 
Overall: 74% (38);  
k: 0.38 [CI: 
0.13;0.63] 
  ESP: 79% (38) 
satisfied or very 
satisfied.  
 
 Acceptable 
(D) 
Acceptable 
(S) 
Pearse et al.,  
  2006, UK [32] 
Retrospective, 
Diverse areas 
   ESP: 77% satisfied 
(126)  
 
 Low (S) 
Razmjou et al.,  
  2013, Canada [7] 
Prospective , 
Shoulder 
Overall: 93% (700);   ESP vs OS: Favour 
ESP (p = 0.004) (100) 
 High (D) 
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k: 0.81 [CI: 
0.74;0.89] 
Acceptable 
(S) 
Trompeter et al.,  
  2010, UK [27] 
 
Retrospective, 
Knee 
 ESP: 66% (50) vs 
arthroscopy 
OS: 82% (50) vs 
arthroscopy 
   Acceptable 
(D) 
Weale and 
Bannister,  
  1995, UK [30] 
Prospective, 
Diverse areas 
   ESP: 89% (n NR)  
OS: 80% (n NR) 
ESP vs OS: No 
difference  
95% (n NR)  Low (S) 
D: Diagnostic agreement; S: Satisfaction; C: Cost; n: participants included in evaluation of D, S or C; ESP: Extended Scope Physiotherapists; OS: Orthopaedic surgeon or consultant; GP: General 
practitioner; RCT: Randomised Controlled Trial; pt.: patient; vs = compared to; k: kappa score; MRI: Magnetic resonance imaging; ICER: ratio of change in incremental benefits of intervention; NR: 
not reported. 
 
 
 
